RenovaLase® is an innovative, non-invasive treatment for the symptoms of vaginal atrophy. It is based on non-ablative photothermal treatment of the vaginal canal. Clinical studies show that it is an effective, fast, and safe procedure that eliminates the need for long-term oestrogen therapy.
The RenovaLase® treatment uses gentle, controlled laser-induced heating of the vaginal tissue to stimulate angiogenesis, fibroblast activity, and new collagen formation — without causing thermal or ablative damage.
The result is increased epithelial thickness and improved vascularisation of the lamina propria, along with a reduction in symptoms such as dryness, itching, irritation, and dyspareunia (pain during intercourse).
Scientific studies show a clear and significant improvement in symptoms of vaginal atrophy. The results demonstrate long-lasting, favourable changes in the vaginal mucosa, with increased collagen, vascularisation, glycogen levels, and epithelial thickness.
Because it eliminates the need for long-term oestrogen therapy, RenovaLase® is also suitable for patients with oestrogen-dependent cancers (such as endometrial or breast cancer) or those with a history of such conditions.
